A detailed history of Plante Moran Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 7,244 shares of AMGN stock, worth $2.29 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,244
Previous 7,258 0.19%
Holding current value
$2.29 Million
Previous $2.06 Million 9.69%
% of portfolio
0.23%
Previous 0.22%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $3,678 - $4,470
-14 Reduced 0.19%
7,244 $2.26 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $62,915 - $75,947
-234 Reduced 3.12%
7,258 $2.06 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $1.34 Million - $1.51 Million
5,251 Added 234.32%
7,492 $2.16 Million
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $1,499 - $1,773
-7 Reduced 0.31%
2,241 $497,000
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $27,772 - $33,849
123 Added 5.79%
2,248 $543,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $10,764 - $13,677
47 Added 2.26%
2,125 $558,000
Q3 2022

Nov 02, 2022

SELL
$224.46 - $253.15 $21,548 - $24,302
-96 Reduced 4.42%
2,078 $468,000
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $32,068 - $35,686
-139 Reduced 6.01%
2,174 $529,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $8,770 - $9,702
-40 Reduced 1.7%
2,313 $559,000
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $139,017 - $159,092
-699 Reduced 22.9%
2,353 $529,000
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $165,782 - $194,234
781 Added 34.39%
3,052 $649,000
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $16,817 - $18,658
-72 Reduced 3.07%
2,271 $554,000
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $46,601 - $54,306
210 Added 9.85%
2,343 $583,000
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $129,395 - $154,086
-598 Reduced 21.9%
2,133 $490,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $12,066 - $14,807
-61 Reduced 2.18%
2,731 $644,000
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $20,228 - $26,828
111 Added 4.14%
2,792 $566,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $71,899 - $92,416
-380 Reduced 12.41%
2,681 $646,000
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $2,263 - $2,712
13 Added 0.43%
3,061 $592,000
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $597,452 - $700,349
-3,584 Reduced 54.04%
3,048 $562,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $58,240 - $65,649
-322 Reduced 4.63%
6,632 $1.26 Million
Q4 2018

Jan 29, 2019

BUY
$178.4 - $208.25 $237,093 - $276,764
1,329 Added 23.63%
6,954 $1.35 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $603,860 - $680,772
3,259 Added 137.74%
5,625 $1.17 Million
Q2 2018

Jul 26, 2018

BUY
$166.05 - $186.51 $90,165 - $101,274
543 Added 29.79%
2,366 $437,000
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $85,731 - $100,188
506 Added 38.42%
1,823 $311,000
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $129,968 - $145,214
770 Added 140.77%
1,317 $229,000
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $91,507 - $104,477
547
547 $102,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.